A recent study indicates that people who discontinue new weight-loss injections like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who end conventional diet and exercise regimens.
Research printed in a leading health publication points out that while overweight individuals frequently drop substantial amounts of their body weight while on the medication, the mass comes back at an estimated rate of nearly a kilo each month after stopping.
"People purchasing these medications must be aware of the risk of fast weight regain when the therapy is stopped," stated researcher Dr. Susan Jebb.
That rate of recovery suggests a return to starting mass in about a year and a half.
Analyzing Approaches
The study, which examined 37 of studies involving over 9,000 of patients, compared the outcomes of these new drugs with other pills.
Scientists emphasize that people who shed pounds through dieting typically see a slower weight regain—perhaps 100 grams monthly—once they finish.
Understanding the Fast Regain
Experts believe the mode of action of the injections explains the accelerated regain.
The injections copy a natural hormone called GLP-1, which helps regulate hunger.
"Long-term administration of GLP-1 concentrations far above than normal could lead to the body to produce less of its own natural GLP-1, and may also lessen sensitivity to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication leads to hunger is uncontrolled, making excessive eating much more probable."
A Chronic Disease?
Health authorities advise the injections for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
Professionals argue that, due to the significant potential of weight regain, the therapy should be considered life-long.
This opinion is supported by pharmaceutical companies, who say that the findings "underscore the persistent character of excess weight," akin to managing diseases like hypertension.
User Accounts
People who have discontinued the jabs explain a intense return of hunger.
"It felt as if something activating and I was suddenly extremely hungry," said an individual.
This challenge is compounded if patients have not adopted permanent lifestyle or habit changes during treatment.
Significant Adoption
Figures suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with demand continuing to grow.
- Adoption is greater among females than men.
- The middle-aged demographic shows the greatest usage rates.
- Many access the medications through private prescriptions rather than public health services.
Ultimately, researchers caution that while these medications are effective tools for shedding pounds, they are not a permanent cure and long-term success likely depends on ongoing behavioural support.
